[
  {
    "date": "2023-12-30",
    "symbol": "CMPX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "000-55939",
    "entityregistrantname": "Compass Therapeutics, Inc.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "82-4876496",
    "entityaddressaddressline1": "80 Guest Street, Suite 601",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2135,
    "cityareacode": 617,
    "localphonenumber": "500-8099",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "CMPX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "auditorfirmid": 596,
    "auditorname": "CohnReznick LLP",
    "auditorlocation": "Melville, New York",
    "entitycentralindexkey": 1738021,
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "cashandcashequivalentsatcarryingvalue": 24228000,
    "marketablesecuritiescurrent": 128233000,
    "prepaidexpenseandotherassetscurrent": 1420000,
    "assetscurrent": 153881000,
    "propertyplantandequipmentnet": 898000,
    "operatingleaserightofuseasset": 1776000,
    "otherassetsnoncurrent": 320000,
    "assets": 156875000,
    "accountspayablecurrent": 4090000,
    "accruedliabilitiescurrent": 2514000,
    "operatingleaseliabilitycurrent": 1197000,
    "liabilitiescurrent": 7801000,
    "operatingleaseliabilitynoncurrent": 536000,
    "liabilities": 8337000,
    "commonstockvalue": 13000,
    "additionalpaidincapitalcommonstock": 463796000,
    "accumulatedothercomprehensiveincomelossnetoftax": 37000,
    "retainedearningsaccumulateddeficit": -315308000,
    "stockholdersequity": 148538000,
    "liabilitiesandstockholdersequity": 156875000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesoutstanding": 127668000,
    "commonstocksharesissued": 127668000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 38120000,
    "generalandadministrativeexpense": 12243000,
    "operatingexpenses": 50363000,
    "operatingincomeloss": -50363000,
    "othernonoperatingincomeexpense": 7869000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -42494000,
    "netincomeloss": -42494000,
    "earningspersharebasic": -0.33,
    "weightedaveragenumberofsharesoutstandingbasic": 127027000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 339000,
    "comprehensiveincomenetoftax": -42155000,
    "sharesoutstanding": 127668000,
    "stockissuedduringperiodsharesnewissues": 952000,
    "stockissuedduringperiodvaluenewissues": 3032000,
    "stockissuedduringperiodsharesstockoptionsexercised": 29000,
    "stockissuedduringperiodvaluestockoptionsexercised": 62000,
    "stockissuedduringperiodsharessharebasedcompensation": 385000,
    "stockissuedduringperiodvaluesharebasedcompensation": -159000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6120000,
    "depreciationandamortization": 699000,
    "sharebasedcompensation": 6120000,
    "marketablesecuritiesamortizationofpremiumanddiscount": -3226000,
    "operatingleaserightofuseassetamortizationexpense": 1191000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -6762000,
    "increasedecreaseinaccountspayable": 708000,
    "increasedecreaseinaccruedliabilities": -9176000,
    "increasedecreaseinoperatingleaseliability": -1202000,
    "netcashprovidedbyusedinoperatingactivities": -40618000,
    "paymentstoacquiremarketablesecurities": 155418000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 182413000,
    "paymentstoacquirepropertyplantandequipment": 30000,
    "netcashprovidedbyusedininvestingactivities": 26965000,
    "proceedsfromissuanceofcommonstock": 3126000,
    "paymentsofstockissuancecosts": 94000,
    "proceedsfromstockoptionsexercised": 62000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 159000,
    "netcashprovidedbyusedinfinancingactivities": 2935000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -10718000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 24228000,
    "marketablesecuritiesunrealizedgainloss": -339000,
    "rule10b51arradoptedflag": "false",
    "nonrule10b51arradoptedflag": "false",
    "rule10b51arrtrmntdflag": "false",
    "nonrule10b51arrtrmntdflag": "false",
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P5Y",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1500000,
    "availableforsalesecuritiesdebtsecurities": 54281000,
    "assetsfairvaluedisclosure": 45189000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 54256000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 74000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 49000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 93117000,
    "debtsecuritiesavailableforsalefairvaluematurityallocatedandsinglematuritydateafteryearonethroughtwo": 35116000,
    "depreciation": 700000,
    "propertyplantandequipmentgross": 5167000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 6267000,
    "accruedmanufacturingexpenses": 8800000,
    "contractualobligation": 6400000,
    "accruedprojectexpensescurrent": 336000,
    "accruedemployeebenefitscurrent": 1938000,
    "otheraccruedliabilitiescurrent": 240000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 4900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 5100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 11000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y7M6D",
    "allocatedsharebasedcompensationexpense": 1998000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 3.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 193000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.74,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7876000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2803000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageremainingcontractualterm": "P9Y2M4D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 1.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 35000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 276000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.29,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedorcancelledinperiodintrinsicvalue": 164000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 3938000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.22,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y5M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 5000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0383,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluegranted": 3537000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 1149000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluenonvested": 5745000,
    "milestonepaymentobligation": 2000000,
    "maximumdevelopmentandregulatorymilestonepayments": 75000000,
    "milestonepaymentspaid": 110000000,
    "numberofoperatingleases": 1,
    "lesseeoperatingleasetermofcontract": "P4Y4M30D",
    "lesseeoperatingleasediscountrate": 0.0625,
    "lesseeoperatingleaseremainingleaseterm": "P2Y4M30D",
    "operatingleasepayments": 1300000,
    "definedcontributionplancostrecognized": 200000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1264000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 543000,
    "lesseeoperatingleaseliabilitypaymentsdue": 1807000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 74000,
    "operatingleaseliability": 1733000,
    "investmentincomeinterest": 7869000,
    "deferredtaxassetsvaluationallowance": 43800000,
    "operatinglosscarryforwards": 65500000,
    "taxcreditcarryforwardamount": 3700000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpenses": 36900000,
    "deferredtaxassetsamortizedresearchanddevelopmentexpenses": 6900000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.079,
    "effectiveincometaxratereconciliationnondeductibleexpense": 0.015,
    "effectiveincometaxratereconciliationresearchcreditpercent": 0.073,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.006,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.371,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 13760000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 3719000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 6387000,
    "deferredtaxassetssection174capitalization": 15525000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2701000,
    "deferredtaxassetsleaseliabilities": 474000,
    "deferredtaxassetscapitalizedlicensingfees": 1484000,
    "deferredtaxassetsother": 234000,
    "deferredtaxassetsgross": 44284000,
    "deferredtaxassetsnet": 485000,
    "deferredtaxliabilitiesleasingarrangements": 485000
  },
  {
    "date": "2022-12-30",
    "symbol": "CMPX",
    "period": "FY",
    "entitycentralindexkey": 1738021,
    "entityregistrantname": "Compass Therapeutics, Inc.",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "000-55939",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "82-4876496",
    "entityaddressaddressline1": "80 Guest Street, Suite 601",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2135,
    "cityareacode": 617,
    "localphonenumber": "500-8099",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "CMPX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "auditorfirmid": 596,
    "auditorname": "CohnReznick LLP",
    "auditorlocation": "Melville, NY U.S.A.",
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 126495000,
    "commonstocksharesoutstanding": 126302000,
    "retainedearningsaccumulateddeficit": -272814000,
    "numberofoperatingsegments": 1,
    "cashandcashequivalentsatcarryingvalue": 34946000,
    "operatingleaserightofuseasset": 2967000,
    "operatingleaseliability": 2935000,
    "depreciation": 800000,
    "accruedmanufacturingexpenses": 8800000,
    "accruedclinicalexpenses": 1300000,
    "contractualobligation": 6400000,
    "stockcancelledduringperiodsharesacquisitions": 95000,
    "stockissuedduringperiodsharesnewissues": 25000000,
    "proceedsfromissuanceofcommonstock": 76237000,
    "paymentsofstockissuancecosts": 495000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.74,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P0Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 2480000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 1216000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 6316000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 5900000,
    "milestonepaymentobligation": 2000000,
    "milestonepaymentspaid": 110000000,
    "numberofoperatingleases": 1,
    "lesseeoperatingleasetermofcontract": "P4Y5M1D",
    "lesseeoperatingleasediscountrate": 0.0625,
    "lesseeoperatingleaseremainingleaseterm": "P2Y7M28D",
    "definedcontributionplanemployermatchingcontributionpercent": 0.04,
    "definedcontributionplancostrecognized": 100000,
    "deferredtaxassetsvaluationallowance": 28000000,
    "operatinglosscarryforwards": 59100000,
    "taxcreditcarryforwardamount": 1400000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpenses": 28600000,
    "deferredtaxassetsamortizedresearchanddevelopmentexpenses": 1800000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 4500000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of estimated useful life or lease term",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 193000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 258000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 1.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 5378000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 3.89,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y2M26D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2277000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageremainingcontractualterm": "P8Y9M21D",
    "stockissuedduringperiodsharesstockoptionsexercised": 6000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 2.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 552000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 4.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 6000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeitedorcancelledinperiodintrinsicvalue": 118000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 2710000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 4.65,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y7M13D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluenonvested": 3447000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvaluevested": 1149000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 29997000,
    "generalandadministrativeexpense": 11658000,
    "operatingexpenses": 41655000,
    "operatingincomeloss": -41655000,
    "othernonoperatingincomeexpense": 2430000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -39225000,
    "netincomeloss": -39225000,
    "earningspersharebasic": -0.37,
    "weightedaveragenumberofsharesoutstandingbasic": 105186000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -302000,
    "comprehensiveincomenetoftax": -39527000,
    "depreciationandamortization": 782000,
    "gainlossonsaleofpropertyplantequipment": 70000,
    "sharebasedcompensation": 5330000,
    "marketablesecuritiesamortizationofpremiumanddiscount": -801000,
    "operatingleaserightofuseassetamortizationexpense": 1122000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 5591000,
    "increasedecreaseinaccountspayable": 2515000,
    "increasedecreaseinaccruedliabilities": 2915000,
    "increasedecreaseinoperatingleaseliability": -1102000,
    "netcashprovidedbyusedinoperatingactivities": -34125000,
    "paymentstoacquiremarketablesecurities": 200119000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 48955000,
    "paymentstoacquirepropertyplantandequipment": 212000,
    "proceedsfromsaleofpropertyplantandequipment": 176000,
    "netcashprovidedbyusedininvestingactivities": -151200000,
    "proceedsfromstockoptionsexercised": 15000,
    "netcashprovidedbyusedinfinancingactivities": 75757000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -109568000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 34946000,
    "marketablesecuritiesunrealizedgainloss": 302000,
    "sharesoutstanding": 126302000,
    "stockholdersequity": 181638000,
    "stockissuedduringperiodvaluenewissues": 3000,
    "stockissuedduringperiodsharessharebasedcompensation": 559000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 5330000,
    "stockissuedduringperiodvaluestockoptionsexercised": 15000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 134620000,
    "debtsecuritiesavailableforsalefairvaluematurityallocatedandsinglematuritydateafteryearonethroughtwo": 17043000,
    "availableforsalesecuritiesdebtsecurities": 87760000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0202,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.94,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1233000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1379000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 543000,
    "lesseeoperatingleaseliabilitypaymentsdue": 3155000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 220000,
    "operatingleaseliabilitycurrent": 1097000,
    "operatingleaseliabilitynoncurrent": 1838000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.056,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.027,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.014,
    "effectiveincometaxratereconciliationotherreconcilingitemspercent": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.252,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 900000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 87998000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 12000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 250000,
    "propertyplantandequipmentgross": 5137000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5568000,
    "propertyplantandequipmentnet": 1567000,
    "accruedprojectexpensescurrent": 10038000,
    "accruedemployeebenefitscurrent": 1556000,
    "otheraccruedliabilitiescurrent": 96000,
    "accruedliabilitiescurrent": 11690000,
    "allocatedsharebasedcompensationexpense": 781000,
    "investmentincomeinterest": 2360000,
    "realizedgainlossondispositionofpropertyplantequipmenttotal": 70000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 12405000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 2687000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3273000,
    "deferredtaxassetssection174capitalization": 7294000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 701000,
    "deferredtaxassetsleaseliabilities": 801000,
    "deferredtaxassetscapitalizedlicensingfees": 1591000,
    "deferredtaxassetsother": 70000,
    "deferredtaxassetsgross": 28822000,
    "deferredtaxassetsnet": 809000,
    "deferredtaxliabilitiesleasingarrangements": 809000,
    "marketablesecuritiescurrent": 151663000,
    "prepaidexpenseandotherassetscurrent": 8182000,
    "assetscurrent": 194791000,
    "otherassetsnoncurrent": 320000,
    "assets": 199645000,
    "accountspayablecurrent": 3382000,
    "liabilitiescurrent": 16169000,
    "liabilities": 18007000,
    "commonstockvalue": 13000,
    "additionalpaidincapitalcommonstock": 454741000,
    "accumulatedothercomprehensiveincomelossnetoftax": -302000,
    "liabilitiesandstockholdersequity": 199645000,
    "assetsfairvaluedisclosure": 47120000
  },
  {
    "date": "2021-12-30",
    "symbol": "CMPX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Compass Therapeutics, Inc.",
    "entitycentralindexkey": 1738021,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": " Yes ",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "000-55939",
    "entitytaxidentificationnumber": "82-4876496",
    "entityaddressaddressline1": "80 Guest Street",
    "entityaddressaddressline2": "Suite 601",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "Massachusetts",
    "entityaddresspostalzipcode": 2135,
    "cityareacode": 617,
    "localphonenumber": "500-8099",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "CMPX",
    "securityexchangename": "Nasdaq",
    "auditorfirmid": 596,
    "auditorname": "CohnReznick LLP",
    "auditorlocation": " Melville, NY U.S.A",
    "cashandcashequivalentsatcarryingvalue": 144514000,
    "prepaidexpenseandotherassetscurrent": 2591000,
    "assetscurrent": 147105000,
    "propertyplantandequipmentnet": 2243000,
    "operatingleaserightofuseasset": 4089000,
    "otherassetsnoncurrent": 320000,
    "assets": 153757000,
    "accountspayablecurrent": 867000,
    "accruedliabilitiescurrent": 8775000,
    "operatingleaseliabilitycurrent": 989000,
    "liabilitiescurrent": 10631000,
    "operatingleaseliabilitynoncurrent": 3048000,
    "liabilities": 13679000,
    "commonstockvalue": 10000,
    "additionalpaidincapitalcommonstock": 373657000,
    "retainedearningsaccumulateddeficit": -233589000,
    "stockholdersequity": -233589000,
    "liabilitiesandstockholdersequity": 153757000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 1000000,
    "commonstocksharesoutstanding": 100832000,
    "researchanddevelopmentexpenseexcludingacquiredinprocesscost": 20337000,
    "generalandadministrativeexpense": 10927000,
    "researchanddevelopmentinprocess": 50618000,
    "operatingexpenses": 81882000,
    "operatingincomeloss": -81882000,
    "othernonoperatingincomeexpense": -299000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -82181000,
    "netincomeloss": -82181000,
    "earningspersharebasicanddiluted": -1.31,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 62870000,
    "sharesoutstanding": 100832000,
    "stockissuedduringperiodvalueacquisitions": 50300000,
    "stockissuedduringperiodsharesacquisitions": 10265000,
    "stockissuedduringperiodvaluenewissues": 127985000,
    "commonsharesissuedinpublicofferingnetshares": 38987000,
    "stockissuedduringperiodsharesvestingofsharebasedawards": 359000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4029000,
    "netloss": -82181000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 8500000,
    "profitloss": -82181000,
    "depreciationandamortization": 566000,
    "gainlossonsaleofpropertyplantequipment": 42000,
    "noncashinterestexpense": 41000,
    "sharebasedcompensation": 4029000,
    "researchanddevelopmentassetacquiredotherthanthroughbusinesscombinationwrittenoff": 50618000,
    "operatingleaserightofuseassetamortizationexpense": 1058000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -534000,
    "increasedecreaseinaccountspayable": -194000,
    "increasedecreaseinaccruedliabilities": 7016000,
    "increasedecreaseinoperatingleaseliability": -1111000,
    "netcashprovidedbyusedinoperatingactivities": -19666000,
    "paymentstoacquirepropertyplantandequipment": 1568000,
    "paymentsforassetacquisitioncosts": 318000,
    "proceedsfromsaleofpropertyplantandequipment": 116000,
    "netcashprovidedbyusedininvestingactivities": -1770000,
    "proceedsfromissuanceofcommonstock": 128267000,
    "paymentsofstockissuancecosts": 281000,
    "repaymentsofdebt": 9400000,
    "netcashprovidedbyusedinfinancingactivities": 118611000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 97175000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 144514000,
    "interestpaidnet": 370000,
    "noncashorpartnoncashrightofuseassetacquiredthroughoperatingleases": 5148000,
    "noncashorpartnoncashacquisitionofbusiness": 50300000,
    "fixedassetcostsincludedinaccruedexpenses": 187000,
    "commonstockcapitalsharesreservedforfutureissuance": 156000,
    "sharesissuedpricepershare": 5,
    "stockholdersequitynotestocksplit": "Upon the closing of the Merger, the common and convertible preferred units of Compass Therapeutics LLC were converted into the Company’s common stock. The Company effected a 0.15-for-one stock conversion ratio for its issued and outstanding convertible preferred units. Common units were converted using the same ratio after factoring in the relevant strike price of each grant.",
    "stockholdersequitynotestocksplitconversionratio1": 0.15,
    "numberofoperatingsegments": 1,
    "cashequivalentsatcarryingvalue": 130000000,
    "operatingleaseliability": 4037000,
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "propertyplantandequipmentusefullife": "5 years",
    "propertyplantandequipmentestimatedusefullives": "Lesser of estimated useful life or lease term",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 5330000,
    "cashandcashequivalentsfairvaluedisclosure": 130005000,
    "assetsfairvaluedisclosure": 130005000,
    "propertyplantandequipmentgross": 7269000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5026000,
    "depreciationdepletionandamortization": 600000,
    "accruedemployeebenefitscurrent": 1601000,
    "accruedresearchanddevelopmentexpensescurrent": 704000,
    "accruedmilestonecurrent": 6000000,
    "otheraccruedliabilitiescurrent": 470000,
    "proceedsfromissuanceofdebt": 15000000,
    "debtinstrumentpaymentterms": "The Company made interest-only payments through March 31, 2020. Beginning in April 2020, the Company was obligated to make monthly principal payments of $625,000 (plus interest) through March 31, 2022 when the note matures.",
    "debtinstrumentperiodicpaymentprincipal": 625000,
    "debtinstrumentmaturitydate": "March 31, 2022",
    "interestexpensedebt": 400000,
    "paymenttoseveralnonaccreditedinvestors": 100000,
    "allocatedsharebasedcompensationexpense": 4029000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 359000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 66000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 1.76,
    "sharebasedcompensationweightedaveragefairvaluegranted": 4596000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 1.7,
    "sharebasedcompensationunvestedoutstanding": 4596000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodintrinsicvalue": 3.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedintrinsicvalue": 3.83,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 12300000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardpercentageofoutstandingstockmaximum": 0.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 5.01,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 7100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0085,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 3659000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1822000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 322000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 1378000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5.02,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaverageexerciseprice": 4.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantedweightedaverageremainingcontractualterm": 9.27,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaverageremainingcontractualterm": 8.67,
    "milestonepaymentsreceived": 5000000,
    "researchanddevelopmentmilestonepayments": 110000000,
    "commercialmilestonepayments": 295000,
    "milestonepaymentandroyaltiesreceived": 185000000,
    "collaborationagreementdate": "October 16, 2014",
    "milestonepayments": 6000000,
    "futuremilestonepayments": 1200000,
    "cashpaymentforlicenseagreement": 1200000,
    "researchanddevelopmentexpense": 1000000,
    "totalexpensetoberecognized": 2900000,
    "numberofoperatinglease": 1,
    "lesseeoperatingleasetermofcontract": " four years and five months",
    "lesseeoperatingleasediscountrate": 0.0625,
    "lesseeoperatingleaseremainingleaseterm": "three years and five month",
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1206000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1348000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1382000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 426000,
    "lesseeoperatingleaseliabilitypaymentsdue": 4362000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 325000,
    "consultingfees": 20000000,
    "interestexpense": 370000,
    "investmentincomeinterest": 29000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.04,
    "definedcontributionplancostrecognized": 100,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.021,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.01,
    "effectiveincometaxratereconciliationdeductionsother": -0.129,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.008,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.1,
    "deferredtaxassetsvaluationallowance": 18100000,
    "operatinglosscarryforwards": 51700000,
    "researchanddevelopmentcreditscarryforwards": 1100000,
    "researchanddevelopmentcreditscarryforwardsexpirationyear": 2031,
    "deferredtaxassetsoperatinglosscarryforwards": 13075000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2716000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 706000,
    "leaseliabilities": 1131000,
    "capitalizedlicensingfees": 1637000,
    "deferredtaxassetsother": 22000,
    "deferredtaxassetsgross": 19287000,
    "deferredtaxassetsnet": 1174000,
    "deferredtaxliabilitiesrightofuseassets": -1116000,
    "deferredtaxliabilitiesother": -58000,
    "businesscombinationconsiderationtransferred1": 50300000,
    "businesscombinationconsiderationtransferredsharevalue": 50300000,
    "accountingandlegalcosts": 300000,
    "legalfees": 300000
  },
  {
    "date": "2020-12-30",
    "symbol": "CMPX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "COMPASS THERAPEUTICS, INC.",
    "entitycentralindexkey": 1738021,
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilenumber": "000-55939",
    "entitytaxidentificationnumber": "82-4876496",
    "entityaddressaddressline1": "80 Guest Street",
    "entityaddressaddressline2": "Suite 601",
    "entityaddresscityortown": "Boston",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2135,
    "cityareacode": 617,
    "localphonenumber": "500-8099",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "security12btitle": "Common Stock, $0.0001 par value per share",
    "tradingsymbol": "CMPX",
    "cashandcashequivalentsatcarryingvalue": 47076000,
    "prepaidexpenseandotherassetscurrent": 3126000,
    "assetscurrent": 50202000,
    "propertyplantandequipmentnet": 1126000,
    "restrictedcashnoncurrent": 263000,
    "otherassetsnoncurrent": 320000,
    "assets": 51911000,
    "accountspayablecurrent": 1061000,
    "accruedliabilitiescurrent": 1571000,
    "longtermdebtcurrent": 7467000,
    "liabilitiescurrent": 10099000,
    "longtermdebtnoncurrent": 1867000,
    "liabilities": 11966000,
    "commonstockvalue": 5000,
    "additionalpaidincapitalcommonstock": 191348000,
    "retainedearningsaccumulateddeficit": -151408000,
    "stockholdersequity": -151408000,
    "liabilitiesandstockholdersequity": 51911000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 300000000,
    "commonstocksharesissued": 1000000,
    "commonstocksharesoutstanding": 51221000,
    "researchanddevelopmentexpense": 300000,
    "generalandadministrativeexpense": 12908000,
    "operatingexpenses": 27812000,
    "operatingincomeloss": -27812000,
    "interestexpense": 908000,
    "othernonoperatingincomeexpense": -748000,
    "nonoperatingincomeexpense": -1656000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -29468000,
    "incometaxexpensebenefit": 32000,
    "netincomeloss": -29500000,
    "earningspersharebasicanddiluted": -0.96,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 30776000,
    "sharesoutstanding": 51221000,
    "stockissuedduringperiodsharesacquisitions": 1000000,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 129870000,
    "reclassificationsoftemporarytopermanentequityshares": -207164000,
    "reclassificationsoftemporarytopermanentequity": -129870000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 30630000,
    "stockissuedduringperiodvaluenewissues": 54231000,
    "stockissuedduringperiodsharesnewissues": 12096000,
    "paymenttononparticipatingmembersuponconsummationofmerger": 69000,
    "paymenttononparticipatingmembersuponconsummationofmergershares": 13000,
    "stockissuedduringperiodsharesvestingofsharebasedawards": 474000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 4016000,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 6300000,
    "profitloss": -29500000,
    "depreciationandamortization": 2404000,
    "gainlossonsaleofpropertyplantequipment": -281000,
    "noncashinterestexpense": 90000,
    "sharebasedcompensation": 4016000,
    "derivativegainlossonderivativenet": -556000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2191000,
    "increasedecreaseinothernoncurrentassets": 290000,
    "increasedecreaseinaccountspayable": 432000,
    "increasedecreaseinaccruedliabilities": -1551000,
    "increasedecreaseinderivativeliabilities": -1050000,
    "netcashprovidedbyusedinoperatingactivities": -26803000,
    "paymentstoacquirepropertyplantandequipment": 106000,
    "proceedsfromsaleofpropertyplantandequipment": 144000,
    "netcashprovidedbyusedininvestingactivities": 38000,
    "proceedsfromissuanceofcommonstock": 60482000,
    "paymentsofstockissuancecosts": 6319000,
    "repaymentsofdebt": 5625000,
    "netcashprovidedbyusedinfinancingactivities": 48538000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 21773000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 47339000,
    "interestpaidnet": 854000,
    "noncashorpartnoncashconversionofpreferredunits": 129870000,
    "entityincorporationdateofincorporation": "2018-03-20",
    "commonstockcapitalsharesreservedforfutureissuance": 772000,
    "sharesissuedpricepershare": 5,
    "stockholdersequitynotestocksplit": "Upon the closing of the Merger, the common and convertible preferred units of Compass Therapeutics LLC were converted into the Company’s common stock. The Company effected a 0.15-for-one stock conversion ratio for its issued and outstanding convertible preferred units. Common units were converted using the same ratio after factoring in the relevant strike price of each grant.",
    "numberofoperatingsegments": 1,
    "cashequivalentsatcarryingvalue": 43600000,
    "restrictedcash": 200000,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2020-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Lesser of estimated useful life or lease term",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3055000,
    "cashandcashequivalentsfairvaluedisclosure": 43631000,
    "assetsfairvaluedisclosure": 43631000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasisunobservableinputsreconciliationgainlossincludedinearnings": -556000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasisunobservableinputsreconciliationsettlements": 1050000,
    "propertyplantandequipmentgross": 7061000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5935000,
    "depreciationdepletionandamortization": 2400000,
    "accruedemployeebenefitscurrent": 976000,
    "accruedresearchanddevelopmentexpensescurrent": 212000,
    "accruedprofessionalfeescurrent": 326000,
    "otheraccruedliabilitiescurrent": 57000,
    "longtermdebtbeforeunamortizeddiscountcurrent": 7500000,
    "debtinstrumentunamortizeddiscountcurrent": 33000,
    "longtermdebtbeforeunamortizeddiscountnoncurrent": 1875000,
    "debtinstrumentunamortizeddiscountnoncurrent": 8000,
    "proceedsfromissuanceofdebt": 15000000,
    "debtinstrumentinterestratestatedpercentage": 0.0625,
    "debtinstrumentbasisspreadonvariablerate1": 0.02,
    "debtinstrumentinterestrateduringperiod": 0.0625,
    "debtinstrumentinterestrateincreasedecrease": 0.05,
    "debtinstrumentpaymentterms": "The Company made interest-only payments through March 31, 2020. Beginning in April 2020, the Company is obligated to make equal monthly principal payments of $625,000 through March 31, 2022 when the note matures.",
    "debtinstrumentfrequencyofperiodicpayment": "monthly",
    "debtinstrumentdateoffirstrequiredpaymentmonthandyear": "2020-04",
    "debtinstrumentperiodicpaymentprincipal": 625000,
    "debtinstrumentmaturitydate": "2022-03-31",
    "successfeepaymentdue": 1100000,
    "interestexpensedebt": 900000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 7500000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 1875000,
    "debtinstrumentcarryingamount": 9375000,
    "paymenttoseveralnonaccreditedinvestors": 100000,
    "allocatedsharebasedcompensationexpense": 4016000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 896000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 474000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 670000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.46,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.66,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 1.75,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y8M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.44,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 4300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M9D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0036,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.0021,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.0051,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.86,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 2159000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2175000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitednumberofshares": 16000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 890000,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaverageexerciseprice": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaverageremainingcontractualterm": "P9Y7M24D",
    "collaborationagreementdate": "2014-10-16",
    "researchanddevelopmentmilestonepayments": 1500000,
    "futuremilestonepayments": 2200000,
    "cashpaymentforlicenseagreement": 300000,
    "clinicalandregulatorymilestonepayments": 80000,
    "leaseexpirationdate1": "2025-05-19",
    "leaseandrentalexpense": 2000000,
    "subleasedescription": "The Company executed a sublease for laboratory and office space in Boston, MA effective in December 2020 with rent beginning in January 2021.",
    "operatingleasesfutureminimumpaymentsduecurrent": 1440000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 1312000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 1345000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 1379000,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 589000,
    "operatingleasesfutureminimumpaymentsdue": 6065000,
    "percentageofownershipinterestincommonstock": 0.05,
    "investmentincomeinterest": 88000,
    "foreigncurrencytransactiongainlossbeforetax": 1000,
    "definedcontributionplanemployermatchingcontributionpercent": 0.04,
    "currentfederaltaxexpensebenefit": 22000,
    "currentstateandlocaltaxexpensebenefit": 10000,
    "currentfederalstateandlocaltaxexpensebenefit": 32000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxexemptincome": -0.08,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.064,
    "effectiveincometaxratereconciliationnondeductibleexpense": -0.005,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.19,
    "effectiveincometaxratecontinuingoperations": -0.001,
    "deferredtaxassetsvaluationallowance": 6635000,
    "operatinglosscarryforwards": 14400000,
    "researchanddevelopmentcreditscarryforwards": 2000000,
    "deferredtaxassetsoperatinglosscarryforwards": 3938000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 2038000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 609000,
    "deferredtaxassetsother": 50000,
    "deferredtaxassetsgross": 6635000
  }
]